Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
9,526
Total Claims
$1.2M
Drug Cost
593
Beneficiaries
$1,941
Cost/Patient
Risk Score Breakdown 15/100
Score components are additive. Read full methodology
Peer Comparison vs. 106,889 Family Practice providers
+7%
Opioid rate vs peers
2.8% vs 2.6% avg
+82%
Cost per patient vs peers
$1,941 vs $1,068 avg
+30%
Brand preference vs peers
11.7% vs 9.0% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
Opioid Prescribing
2.8%
Opioid Rate
264
Opioid Claims
$2,883
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 1,096 claims · $930K
Generic: 8,308 claims · $212K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Budesonide/Formoterol Fumarate | 116 | $102K |
| Apixaban | 52 | $76K |
| Dulaglutide | 34 | $70K |
| Sitagliptin Phosphate | 41 | $64K |
| Empagliflozin | 40 | $58K |
| Semaglutide | 18 | $53K |
| Insulin Glargine,hum.Rec.Anlog | 36 | $46K |
| Insulin Aspart | 18 | $41K |
| Sitagliptin Phos/Metformin Hcl | 17 | $28K |
| Insulin Detemir | 25 | $27K |
| Linaclotide | 21 | $27K |
| Sacubitril/Valsartan | 11 | $22K |
| Albuterol Sulfate | 355 | $18K |
| Tirzepatide | 11 | $18K |
| Insulin Detemir | 19 | $15K |
Prescribing Profile
Patient Profile
66
Avg Age
66%
Female
1.45
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About